熱門資訊> 正文
ANI Pharmaceuticals在FDA最终批准后推出了睾酮凝胶
2024-10-25 20:48
- ANI Pharmaceuticals (NASDAQ:ANIP) announced that following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06%.
- ANI’s Estradiol Gel, 0.06% is the generic version of the reference listed drug EstroGel Gel, 0.06%.
- Source: Press Release
More on ANI Pharmaceuticals
- ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market
- ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript
- ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028
- ANI earns bullish view at Piper Sandler on portfolio mix
- ANI Pharmaceuticals falls amid Truist downgrade on delayed Alimera deal close
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
